Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Government Shutdown Causes Backlog Of 100 Device Submissions, With More Expected

This article was originally published in The Gray Sheet

Executive Summary

CDRH says it received 101 device submissions during the two-week government shutdown, and has logged them into its system. The center also expects an increased number of submissions in the coming weeks, but remains confident it will meet its MDUFA review timelines.

You may also be interested in...

As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?

Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.

US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal

Congress reached agreement Jan. 22 to end the three-day US government shutdown in a continuing resolution bill that includes a two-year device-tax suspension.

FDA Reports Declining 510(k) Times, And Other Improvements

The most recent user-fee program trends report from FDA, with data current to March 31, 2014, shows improvements in 510(k) review metrics.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts